NSC95397 Is a Novel HIV-1 Latency-Reversing Agent
The latent viral reservoir represents one of the major barriers to curing HIV-1. Focus on the “kick and kill” (also called “shock and kill”) approach, in which virus expression is reactivated, and then cells producing virus are selectively depleted, has led to the discovery of many latency-reversing...
Saved in:
| Main Authors: | Randilea Nichols Doyle, Vivian Yang, Yetunde I. Kayode, Robert Damoiseaux, Harry E. Taylor, Oliver I. Fregoso |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/16/11/1783 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Latency Reversing Agents and the Road to an HIV Cure
by: Louis Tioka, et al.
Published: (2025-02-01) -
HIV Tat as a latency reversing agent: turning the tables on viral persistence
by: Bridget M. Fisher, et al.
Published: (2025-04-01) -
Compounds producing an effective combinatorial regimen for disruption of HIV‐1 latency
by: Pargol Hashemi, et al.
Published: (2017-12-01) -
Effects of aging on regular and express latencies of vergence
by: Qing Yang, et al.
Published: (2009-01-01) -
Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size
by: Erick De La Torre Tarazona, et al.
Published: (2025-07-01)